Mohamad Mohty, Head of the Clinical Hematology and Cellular Therapy Department at Saint-Antoine Hospital, Sorbonne University, shared a post on X:
“A powerhouse ASH25 Plenary today: time-limited therapy reshaping CLL, new insights for SCD, a novel DLBCL subtype uncovered, TP53-mutant CHIP challenged, IV iron clarified, and PARADIGM redefining AML induction.
Science moving fast, and changing practice.”
Read More updates from ASH25 on OncoDaily.